相关实验视频

Updated: May 10, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K

酵素胺的杂质概况和稳定性分析:鉴定,基因毒性评估和开发用于关键杂质的UHPLC方法

Burcu Oktar Uzun1, Pelin Kaygu2, Elif Keskin2

  • 1DEVA Holding A.S., R&D Center, Karaağaç Mh. Fatih Blv. No: 26, Kapaklı, Tekirdağ 59510, Türkiye; Ankara University, Graduate School of Health Sciences, Ankara, Türkiye; Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara 06560, Türkiye.

Journal of pharmaceutical and biomedical analysis
|May 1, 2025
PubMed
概括

这项研究旨在识别和控制前列腺癌药物恩扎胺中的杂质. 它为潜在的基因毒性杂质Enzal-2和Enzal-2A设定了安全限值,以确保药物的质量和患者的安全.

关键词:
降解降解是一种降解.酵素胺是什么 酵素胺是什么杂质是指不纯净的东西.变异性 变异性 变异性在UHPLC中,UHPLC是验证 验证 验证 验证

更多相关视频

A Simple Method for Automated Solid Phase Extraction of Water Samples for Immunological Analysis of Small Pollutants07:26

A Simple Method for Automated Solid Phase Extraction of Water Samples for Immunological Analysis of Small Pollutants

Published on: January 1, 2016

13.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K

相关概念视频

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...